An Update on Role of Vesicular Carriers in Skin Cancer

Skin cancer is one of the leading and most significant threats to the current scenario, mainly due to global warming occurring across the world. Anticancer drugs either completely kill most cancer cells or, in some ways, modify their growth. However, the selectivity of most medications is constrained, which makes them the most toxic drugs used in therapy. However, technologies and innovations have attracted the attention of contemporary developments with the help of numerous discoveries in nearly every subject. Additionally, vesicular carriers have been explored for drug discovery in a protracted manner. These carriers improve the drug's permeability, ensure that the drug is delivered at the target site and from approaches such as gels and patches, and, for this reason, nullify the troubles related to the distribution, resistance, specificity, selectivity, and systemic toxicity of drugs. This review highlights the etiology, therapies, and briefings of various vesicular carriers for the treatment of skin cancer. Keywords Transdermal drug delivery, carriers, vesicular, skin, cancer